MANF signaling is an emerging therapeutic target in neurodegenerative diseases, diabetes mellitus, stroke, retinal damage, and Wolfram syndrome, a genetic disorder characterized by diabetes and retinal and neuronal degeneration. This evidence concerns the gene MANF and Stroke.